These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11231007)

  • 1. A suicide-substrate mechanism for hydrolysis of beta-lactams by an anti-idiotypic catalytic antibody.
    Lefevre S; Debat H; Thomas D; Friboulet A; Avalle B
    FEBS Lett; 2001 Jan; 489(1):25-8. PubMed ID: 11231007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional mimicry: elicitation of a monoclonal anti-idiotypic antibody hydrolizing beta-lactams.
    Avalle B; Thomas D; Friboulet A
    FASEB J; 1998 Aug; 12(11):1055-60. PubMed ID: 9707178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of a functional scFv fragment of an anti-idiotypic antibody with a beta-lactam hydrolytic activity.
    Padiolleau-Lefèvre S; Débat H; Phichith D; Thomas D; Friboulet A; Avalle B
    Immunol Lett; 2006 Feb; 103(1):39-44. PubMed ID: 16325271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overpassing an aberrant V(kappa) gene to sequence an anti-idiotypic abzyme with (beta)-lactamase-like activity that could have a linkage with autoimmune diseases.
    Debat H; Avalle B; Chose O; Sarde CO; Friboulet A; Thomas D
    FASEB J; 2001 Mar; 15(3):815-22. PubMed ID: 11259400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antiidiotypic approach to obtaining a proteolytic antibody.
    Smirnov IV; Vorobiev II; Friboulet A; Avalle B; Thomas D; Knorre VD; Gabibov AG; Ponomarenko NA
    Dokl Biochem Biophys; 2008; 420():105-7. PubMed ID: 18680902
    [No Abstract]   [Full Text] [Related]  

  • 6. Production and characterization of monoclonal anti-idiotypic antibody exhibiting a catalytic activity similar to carboxypeptidase A.
    Hu R; Xie GY; Zhang X; Guo ZQ; Jin S
    J Biotechnol; 1998 Apr; 61(2):109-15. PubMed ID: 9654744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multitarget selection of catalytic antibodies with β-lactamase activity using phage display.
    Shahsavarian MA; Chaaya N; Costa N; Boquet D; Atkinson A; Offmann B; Kaveri SV; Lacroix-Desmazes S; Friboulet A; Avalle B; Padiolleau-Lefèvre S
    FEBS J; 2017 Feb; 284(4):634-653. PubMed ID: 28075071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalytic mechanism of an abzyme displaying a beta-lactamase-like activity.
    Avalle B; Débat H; Friboulet A; Thomas D
    Appl Biochem Biotechnol; 2000; 83(1-3):163-9; discussion 169-71, 297-313. PubMed ID: 10826957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal anti-idiotypic antibodies as functional internal images of enzyme active sites: production of a catalytic antibody with a cholinesterase activity.
    Izadyar L; Friboulet A; Remy MH; Roseto A; Thomas D
    Proc Natl Acad Sci U S A; 1993 Oct; 90(19):8876-80. PubMed ID: 8415624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalysis by anti-idiotypic antibodies.
    Avalle B; Friboulet A; Thomas D
    Chem Immunol; 2000; 77():80-8. PubMed ID: 11706707
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiidiotypic antibodies as functional internal images of enzyme-active sites.
    Friboulet A; Izadyar L; Avalle B; Roseto A; Thomas D
    Ann N Y Acad Sci; 1995 Mar; 750():265-70. PubMed ID: 7785852
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-idiotypic antibody mimics proteolytic function of parent antigen.
    Ponomarenko NA; Pillet D; Paon M; Vorobiev II; Smirnov IV; Adenier H; Avalle B; Kolesnikov AV; Kozyr AV; Thomas D; Gabibov AG; Friboulet A
    Biochemistry; 2007 Dec; 46(50):14598-609. PubMed ID: 18020454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of pyridoxal 5'-phosphate dependent catalytic antibodies.
    Khomutov RM
    Biochemistry (Mosc); 2002 Oct; 67(10):1085-8. PubMed ID: 12460106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyclonal catalytic anti-idiotypic antibodies with a beta-lactamase activity.
    Avalle B; Mistro D; Thomas D; Friboulet A
    Ann N Y Acad Sci; 1996 Oct; 799():172-5. PubMed ID: 8958088
    [No Abstract]   [Full Text] [Related]  

  • 15. A rat monoclonal antibody that catalyses the hydrolysis of a nitrophenyl-beta-lactam.
    Ostler EL; Dean CJ; Barber N; Valeri M; James S; Resmini M; Boucher G; Romanov N; Brocklehurst K; Gallacher G
    Biochem Biophys Res Commun; 2002 Nov; 299(2):273-6. PubMed ID: 12437982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigations into the development of catalytic activity in anti-acetylcholinesterase idiotypic and anti-idiotypic antibodies.
    Johnson G; Moore SW
    J Mol Recognit; 2009; 22(3):188-96. PubMed ID: 19051205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of inhibitory monoclonal antibodies. A critical step for producing anti-idiotypic catalytic antibodies.
    Avalle B; Friboulet A; Thomas D
    Ann N Y Acad Sci; 1998 Dec; 864():118-30. PubMed ID: 9928086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiidiotypic antibodies exhibiting an acetylcholinesterase abzyme activity.
    Joron L; Izadyar L; Friboulet A; Remy MH; Pancino G; Roseto A; Thomas D
    Ann N Y Acad Sci; 1992 Nov; 672():216-23. PubMed ID: 1476371
    [No Abstract]   [Full Text] [Related]  

  • 19. Catalytic antibodies with acetylcholinesterase activity.
    Johnson G; Moore SW
    J Immunol Methods; 2002 Nov; 269(1-2):13-28. PubMed ID: 12379349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new monoclonal anti-idiotypic catalytic antibody with a CPA-like activity.
    Du M; Guo Z; Jin S
    Bioorg Med Chem Lett; 1999 Jun; 9(11):1487-92. PubMed ID: 10386922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.